Sponsor content
345 result(s) found, displaying 21 to 30
-
Feb-2026Prescription medicine evaluationActive ingredient: datopotamab deruxtecan.
-
-
Designation or determinationPriority review
-
Jan-2026Prescription medicine evaluationActive ingredient: trastuzumab deruxtecan.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KAVIGALE, sipavibart, 300 mg in 2 mL (150 mg/mL), Solution for injection/infusion vial.
-
Prescription medicine registrationActive ingredients: trastuzumab deruxtecan.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DATROWAY datopotamab deruxtecan 100 mg powder for injection vial.
-
Prescription medicine registrationActive ingredients: Influenza virus.
-
Prescription medicine registrationActive ingredients: trastuzumab deruxtecan.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Tezspire tezepelumab 210 mg in 1.91mL solution for Injection prefilled pen.